About this Research Topic
Stellate Ganglion Blockade (SGB) is increasingly recognized as a significant therapeutic modality in the treatment of various clinical disorders, including regional pain syndromes, autonomic dysfunctions, and certain neurological and cardiovascular conditions. Recently, the adoption of ultrasound-guided SGB has marked a pivotal advancement, proving to be more effective and safer compared to traditional blind injection techniques. Despite these advancements, a thorough evaluation and broader understanding of SGB's applications remain crucial. Research leveraging animal models, which share anatomical similarities with human stellate ganglions, is essential for developing new techniques and expanding our knowledge.
This Research Topic aims to consolidate cutting-edge research on the basic and clinical aspects of SGB and foster a dynamic exchange of innovative ideas among researchers and clinicians. By gathering novel studies that push the boundaries of current knowledge and technology, this platform will enhance the scientific community's capacity to understand and implement SGB in various therapeutic contexts.
To gather further insights in the realm of SGB research, we welcome articles addressing, but not limited to, the following themes:
o Innovations in clinical and basic SGB applications.
o New technical improvements for effective and safe SGB administration.
o Development and use of new agents enhancing the duration and efficacy of SGB.
o Insights into neural circuits and mechanisms influenced by SGB.
o Potential advancements in animal models to revolutionize SGB's clinical use.
In addition to original research, we encourage submissions across a variety of article types, including systematic reviews, case reports, and perspectives, ensuring scientific rigor and relevance to the evolving field of SGB.
Dr Lipov is a co-founder and the GMO of Stella Center. The other editors declare no conflicts of interests.
This Research Topic aims to consolidate cutting-edge research on the basic and clinical aspects of SGB and foster a dynamic exchange of innovative ideas among researchers and clinicians. By gathering novel studies that push the boundaries of current knowledge and technology, this platform will enhance the scientific community's capacity to understand and implement SGB in various therapeutic contexts.
To gather further insights in the realm of SGB research, we welcome articles addressing, but not limited to, the following themes:
o Innovations in clinical and basic SGB applications.
o New technical improvements for effective and safe SGB administration.
o Development and use of new agents enhancing the duration and efficacy of SGB.
o Insights into neural circuits and mechanisms influenced by SGB.
o Potential advancements in animal models to revolutionize SGB's clinical use.
In addition to original research, we encourage submissions across a variety of article types, including systematic reviews, case reports, and perspectives, ensuring scientific rigor and relevance to the evolving field of SGB.
Dr Lipov is a co-founder and the GMO of Stella Center. The other editors declare no conflicts of interests.
Keywords: stellate ganglion, stellate ganglion blockade, Pain Management, Autonomic Dysfunction, Technological Advancements in SGB
Important Note: All contributions to this Research Topic must be within the scope of the section and journal to which they are submitted, as defined in their mission statements. Frontiers reserves the right to guide an out-of-scope manuscript to a more suitable section or journal at any stage of peer review.
